BAK · Braskem S.A. · Stock research

Current Thesis

The operating result and the security have decoupled. Braskem released Q2 2026 on 2026-08-14: recurring EBITDA of US$1.043B at a 24.2% margin, more than five times Q1 2026's US$192M, with net income of US$664M — and the ADR fell 5.56% on the day to close at $1.95 on the pipeline's adjusted series. Management framed the quarter as "tactical capture of value in a volatile environment, not as a structural change in the cycle," pointing to Middle East supply disruption and guiding spreads to normalize through H2 2026 and 2027. What prices the equity is the 60-day São Paulo precautionary injunction granted 2026-06-26, which expires 2026-08-24, and whether the extrajudicial reorganization (recuperação extrajudicial) covering more than US$10B of debt is filed with creditor support before then. Reuters reported on 2026-08-12 that talks were advanced and a filing could come inside August, structured around a 90-day stay. The narrative leg an investor would be buying is recovery value on a plan that leaves the common intact, plus a 2027 up-cycle option — not a momentum theme.

Bullish and bearish views on Braskem S.A.

The model's bull view on Braskem S.A. (BAK), in brief: Q2 2026 proved the asset base can print (2026-08-14). The bear view: The prior bear-confirm level registered. Both cases follow in full.

Bull Case

• Q2 2026 proved the asset base can print (2026-08-14). Recurring EBITDA US$1.043B, 24.2% margin; Brazil US$869M (+261% QoQ), US and Europe US$147M. An operating platform capable of a billion-dollar quarter is a different negotiating object than a melting one.
• Capex discipline is real. The 2026 budget is US$485M with only ~35% spent through H1 2026, and Q2 interest paid was US$136M against ~US$210M of recurring quarterly cash generation after US$547M of working-capital consumption.
• An extrajudicial route preserves more equity optionality than a court-run reorganization. The reported structure carries a 90-day stay while a plan is negotiated; a deal approved by a judge rather than administered by one is the path in which the common is least likely to be extinguished.
• Two controlling holders with reasons to defend residual value. IG4 Capital holds ~50.1% of voting capital via the Shine I fund and Petrobras ~47% of voting rights.

Bear Case

• The prior bear-confirm level registered. The 2026-07-26 coverage flagged a weekly close below $2.00 as confirmation the market was pricing equity impairment; the 2026-08-14 close of $1.95 delivered it, with the 3-month return at -60.2%.
• Revenue missed while EBITDA surged. Q2 net revenue of US$4.31B came in under the US$4.67B consensus — the beat was spread-driven and management has already told holders it reverses.
• The August deadline is hard. If no deal is in place by 2026-08-24, enforcement protection lapses and a formal court-run restructuring becomes the live path. The opening term sheet — five-year extension, unsecured status retained, 100% PIK from July 2026 through December 2028, then +200bps — was rejected by creditors demanding shareholder burden-sharing and a Petrobras injection that has not been forthcoming.
• A second restructuring track is open. Braskem Idesa's ~US$2B of Mexican debt is under review with a possible Chapter 11, on a timeline roughly aligned to the Brazilian process.
• Chapter 15 recognition (SDNY, filed 2026-06-26) and the 2026-06-30 rating actions — Fitch to C, S&P into default territory — describe the parent, not a subsidiary.

Setup & Price Structure

Reference close 2026-08-14: $1.95, -61.2% from the 52-week high of $5.02 on the split/dividend-adjusted series; RSI(14) 25.3. Investing.com cited an unadjusted ADR 52-week range of $1.83–$5.40 in its 2026-08-14 earnings coverage, putting the print-day close within roughly 7% of the low end of that range. There is no base: the $2.00 shelf that held through late July broke in the week of the Q2 release, and price is making lows into the 2026-08-24 expiry. Oversold readings inside a restructuring are a function of where the capital structure settles.

The narrative is dead. The dating is specific — the equity narrative broke on 2026-06-26 (injunction plus Chapter 15) and 2026-06-30 (Fitch C, S&P default), and the 2026-08-14 tape rejected the strongest operating quarter in years. Coverage is now credit-desk and Brazilian business press (Reuters 2026-08-12, InfoMoney and Money Times 2026-08-13) rather than equity-momentum flow.

Crowding and positioning observables: no retail-sentiment clustering is visible in the coverage — the flow is distressed-debt reporting; the earnings binary is behind, not ahead (Q2 released 2026-08-14); price sits roughly 61% below the adjusted 52-week high with no rising moving average to be extended above; the Street's average 12-month target was reported near $1.50 following JPMorgan's 2026-06-30 downgrade on restructuring risk, i.e. below the last close. Dilution risk here would arrive as a plan term, and none has been filed.

Catalyst Calendar (next 30 days)

• ~2026-09 (est.) — Braskem Idesa restructuring decision on ~US$2B, Chapter 11 among the options.

Elapsed catalysts

• 2026-08-24 — 60-day precautionary injunction from the 2nd Bankruptcy and Restructuring Court of São Paulo (granted 2026-06-26) expires. (passed 2d ago)
• ~2026-08-24 (est.) — potential extrajudicial recovery filing; Reuters 2026-08-12 reported advanced creditor talks and a 90-day stay structure covering >US$10B of debt in Brazil, the US and Europe. (passed 2d ago)

What Would Change Our Mind

The structure that matters is legal, and it breaks in two directions. Bear-confirming: 2026-08-24 passing with no extrajudicial filing and no extension, an RJ (full judicial reorganization) petition instead, or a filed plan carrying debt-for-equity conversion — any of which prices the common as a stub. The gradeable version is a weekly close below $1.80, which takes out the August low zone and the $1.83 floor cited on the unadjusted ADR. Bull-confirming, and the only condition under which the distressed read stops holding: a filed and creditor-supported plan that extends maturities without converting debt to equity, alongside a reclaim of the $3.00–$3.30 shelf on expanding volume.

Correlation Notes

Day-to-day, the ADR tracks the B3-listed preferred line and BRL/USD more than the US petrochemical complex. Fundamentals key off polyolefin spreads — the Q2 2026 surge came from a Middle East supply shock that management expects to unwind — plus naphtha and US ethane feedstock costs, which links the operating result loosely to LYB, DOW and WLK spread commentary. Petrobras is both a ~47% voting holder and a repeatedly floated rescuer, so PBR headlines carry event risk into this name. Broader EM-Brazil beta (EWZ) is a secondary driver; from here, the court docket dominates all of it.